A single ascending dose study to characterize the pharmacokinetics, safety, and tolerability of SAR441566 in healthy adult Japanese male participants.

Trial Identifier: PKM17860
Sponsor: Sanofi
Start Date: May 2023
Primary Completion Date: July 2023
Study Completion Date: July 2023
Condition: Rheumatoid Arthritis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, California Glendale, California, United States, 91206